Systemic lupus erythematosus | systemic lupus erythematosus | Scleroderma | Systemic functional grammar | Systemic administration | scleroderma |
Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that neutralizes TGF beta 1 which had been chosen for further development for the treatment of diffuse cutaneous systemic sclerosis, also known as scleroderma.